Skip to main content

Table 3 Medication use at enrolment

From: Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor

Medication Use at Presentation

Medications

No

Hydroxycarbamide

61

Busulfan

1

Imatinib

1

Hydroxycarbamide+Imatinib

1

Hydroxycarbamide+Busulfan

1

No anticancer drugs

41

Total

106